These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 3904805)

  • 1. Maintenance treatment of psoriasis by Tigason: a double-blind randomized clinical trial.
    Dubertret L; Chastang C; Beylot C; Bazex J; Rognin C; Touraine R
    Br J Dermatol; 1985 Sep; 113(3):323-30. PubMed ID: 3904805
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A double-blind comparison of acitretin and etretinate in combination with bath PUVA in the treatment of extensive psoriasis.
    Lauharanta J; Geiger JM
    Br J Dermatol; 1989 Jul; 121(1):107-12. PubMed ID: 2527054
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tigason (etretinate) in prevention of recurrence of superficial bladder tumors. A double-blind clinical trial.
    Alfthan O; Tarkkanen J; Gröhn P; Heinonen E; Pyrhönen S; Säilä K
    Eur Urol; 1983; 9(1):6-9. PubMed ID: 6337054
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Psoriasis therapy with the aromatic retinoid Ro 10-9359 (Tigason)].
    Sönnichsen N; Harnack K; Barth J; Heilmann S; Jäger K; Metz D; Schiller F
    Z Hautkr; 1983 Sep; 58(17):1257-67. PubMed ID: 6636927
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A randomized double-blind comparison of PUVA-etretinate and PUVA-placebo in the treatment of chronic plaque psoriasis.
    Parker S; Coburn P; Lawrence C; Marks J; Shuster S
    Br J Dermatol; 1984 Feb; 110(2):215-20. PubMed ID: 6365147
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of etretinate (Tigason) in clearing and prevention of relapse of palmoplantar pustulosis.
    Lassus A; Lauharanta J; Juvakoski T; Kanerva L
    Dermatologica; 1983; 166(4):215-9. PubMed ID: 6343148
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Randomized double-blind multicenter study comparing acitretin-PUVA, etretinate-PUVA and placebo-PUVA in the treatment of severe psoriasis.
    Saurat JH; Geiger JM; Amblard P; Beani JC; Boulanger A; Claudy A; Frenk E; Guilhou JJ; Grosshans E; Mérot Y
    Dermatologica; 1988; 177(4):218-24. PubMed ID: 2976000
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A double blind clinical trial of Tigason (Ro 10-9359) versus placebo in psoriasis.
    Jakubowicz K; Gruca S; Nowakowski H
    Acta Univ Carol Med (Praha); 1986; 32(3-4):229-32. PubMed ID: 3324721
    [No Abstract]   [Full Text] [Related]  

  • 9. A double-blind controlled trial of etretinate (Tigason) and ibuprofen in psoriatic arthritis.
    Hopkins R; Bird HA; Jones H; Hill J; Surrall KE; Astbury C; Miller A; Wright V
    Ann Rheum Dis; 1985 Mar; 44(3):189-93. PubMed ID: 3883917
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A comparison of PUVA-etretinate and PUVA-placebo for palmoplantar pustular psoriasis.
    Lawrence CM; Marks J; Parker S; Shuster S
    Br J Dermatol; 1984 Feb; 110(2):221-6. PubMed ID: 6696838
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Treatment of psoriasis with aromatic retinoid derivatives (Tigason) (double-blind method)].
    Gruca S; Jakubowicz K
    Przegl Dermatol; 1984; 71(3):273-8. PubMed ID: 6395197
    [No Abstract]   [Full Text] [Related]  

  • 12. Etretinate (Tigason) and betamethasone valerate (Celeston valerate) in the treatment of psoriasis. A double-blind, randomized, multicenter trial.
    Christiansen JV; Holm P; Møller R; Reymann F; Schmidt H
    Dermatologica; 1982 Sep; 165(3):204-7. PubMed ID: 6751889
    [No Abstract]   [Full Text] [Related]  

  • 13. Etretinate in severe psoriasis. Results of double-blind study and maintenance therapy in pustular psoriasis.
    Wolska H; Jablonska S; Bounameaux Y
    J Am Acad Dermatol; 1983 Dec; 9(6):883-9. PubMed ID: 6358282
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A clinical evaluation of the effects of an aromatic retinoid (Tigason), combination of retinoid and PUVA, and PUVA alone in severe psoriasis.
    Lauharanta J; Juvakoski T; Lassus A
    Br J Dermatol; 1981 Mar; 104(3):325-32. PubMed ID: 7011359
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PUVA, etretinate, and PUVA-etretinate therapy for pustulosis palmoplantaris. A placebo-controlled comparative trial.
    Rosén K; Mobacken H; Swanbeck G
    Arch Dermatol; 1987 Jul; 123(7):885-9. PubMed ID: 3300565
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A randomized trial of etretinate (Tigason) in palmoplantar pustulosis.
    Foged E; Holm P; Larsen PO; Laurberg G; Reymann F; Roesdahle K; Ullman S
    Dermatologica; 1983; 166(4):220-3. PubMed ID: 6343149
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combination therapy of oral methoxypsoralen: photochemotherapy (PUVA) and an aromatic retinoid (etretinate, tigason) in the treatment of psoriasis.
    Thirumoorthy T; Tham SN; Tan YC
    J Dermatol; 1986 Apr; 13(2):132-6. PubMed ID: 3531270
    [No Abstract]   [Full Text] [Related]  

  • 18. Treatment of psoriasis by oral PUVA therapy combined with aromatic retinoid (Ro 10-9359; Tigason).
    Grupper C; Berretti B
    Dermatologica; 1981; 162(5):404-13. PubMed ID: 7250475
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of palmoplantar pustulosis with Tigason.
    Thune P
    Dermatologica; 1982 Jan; 164(1):67-72. PubMed ID: 7040131
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A double-blind comparison of acitretin and etretinate in the treatment of severe psoriasis. Results of a Nordic multicentre study.
    Kragballe K; Jansén CT; Geiger JM; Bjerke JR; Falk ES; Gip L; Hjorth N; Lauharanta J; Mork NJ; Reunala T
    Acta Derm Venereol; 1989; 69(1):35-40. PubMed ID: 2563606
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.